Yongjie Xin Selected Research

RNA (Ribonucleic Acid)

1/2022	Distinct binding pattern of EZH2 and JARID2 on RNAs and DNAs in hepatocellular carcinoma development.
1/2020	SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yongjie Xin Research Topics

Disease

5	Neoplasms (Cancer) 01/2022 - 01/2018
3	Hepatocellular Carcinoma (Hepatoma) 12/2022 - 01/2018
3	Liver Neoplasms (Liver Cancer) 02/2021 - 01/2020
1	Carcinoma (Carcinomatosis) 01/2022
1	Obesity 12/2021
1	Hypoxia (Hypoxemia) 02/2021
1	Stroke (Strokes) 01/2021
1	Ischemic Stroke 01/2021
1	Embolic Stroke 01/2021
1	Infarction (Infarctions) 01/2021
1	Ischemia 01/2021
1	Cholangiocarcinoma 01/2019

Drug/Important Bio-Agent (IBA)

2	ChromatinIBA 12/2022 - 01/2022
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2020
2	MicellesIBA 02/2021 - 01/2018
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Interleukin-27 (Interleukin 27)IBA 12/2021
1	Immunologic Factors (Immunomodulators)IBA 12/2021
1	NanogelsIBA 02/2021
1	Cidofovir (Vistide)FDA Link 02/2021
1	Phosphorylcholine (Phosphocholine)IBA 02/2021
1	polyethylene glycol polyethyleneimine nanogelIBA 02/2021
1	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021
1	Tight Junction ProteinsIBA 01/2021
1	Circulating Tumor DNAIBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2020
1	MethyltransferasesIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	N-methyladenosineIBA 01/2020
1	MitogensIBA 01/2020
1	Long Noncoding RNAIBA 01/2019
1	Therapeutic UsesIBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 01/2018
1	caprolactoneIBA 01/2018

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2018
2	Immunotherapy 12/2021 - 10/2020
1	Surgical Instruments (Clip) 01/2022
1	Bariatric Surgery 12/2021
1	Aftercare (After-Treatment) 01/2021